Physician profile
Niren Angle
NPI 1720045412
$12,340.43
in general payments reported to CMS, 2019-2025
20 companies · $877 in 2025
The $877 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,767 · 2020: $1,824 · 2021: $948 · 2022: $175 · 2023: $409 · 2024: $340 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,688.66 | 2019-2025 | Jeti Peripheral Catheter, Esprit, Herculink Elite |
| Applied Medical Resources Corporation | $2,250.00 | 2019-2020 | |
| Boston Scientific Corporation | $1,047.53 | 2021-2025 | Eluvia, Varithena Administration Pack |
| Shockwave Medical, INC | $845.94 | 2019-2025 | |
| Cvrx, INC. | $391.50 | 2023-2025 | Barostim Neo System |
| Reflow Medical INC | $238.49 | 2025 | |
| Inari Medical, INC. | $199.94 | 2019-2022 | |
| Medtronic, INC. | $170.81 | 2023 | Endurant Iis |
| Silk Road Medical, INC. | $155.58 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $110.75 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Atricure, INC. | $62.06 | 2023-2025 | Atriclip Laa Exclusion System |
| Venclose INC. | $40.93 | 2019-2020 | |
| Mozarc Medical US LLC | $19.79 | 2024 | Chameleon |
| Cardiovascular Systems INC. | $19.77 | 2021 | |
| Becton, Dickinson and Company | $19.23 | 2025 | Rotarexs 6 F X 135 Cm |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.18 | 2022 | |
| Penumbra, INC. | $17.06 | 2019 | |
| Bard Access Systems, INC. | $16.66 | 2019 | |
| Abiomed | $14.13 | 2024 | Impella |
| Philips North America LLC | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niren Angle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.